Real world outcomes with elotuzumab-based therapies for patients with relapsed refractory multiple myeloma: a Mayo Clinic experience by Ricardo D. Parrondo, Saurav Das, Hanna Sledge, Leif Bergsagel, Rafael Fonseca, Nelson Leung, Prashant Kapoor, Morie Gertz, Francis Buadi, Angela Dispenzieri, Jamie Elliott, Andre Fernandez, Caitlin Flott, Asher A. Chanan-Khan, Vivek Roy, Sikander Ailawadhi

Get full text

Localized and historical hypermobile spectrum disorders share self-reported symptoms and comorbidities with hEDS and HSD by DeLisa Fairweather, DeLisa Fairweather, DeLisa Fairweather, DeLisa Fairweather, Katelyn A. Bruno, Katelyn A. Bruno, Katelyn A. Bruno, Ashley A. Darakjian, Ashley A. Darakjian, Frances C. Wilson, Frances C. Wilson, Jessica J. Fliess, Emma F. Murphy, S. Christian Kocsis, Max W. Strandes, Gabriel J. Weigel, Alayna M. Puls, Cameron J. Hartmoyer, Charwan Hamilton, Emily R. Whelan, Jessica M. Gehin, Stacey M. Menton, Hanna Sledge, David O. Hodge, Shilpa Gajarawala, Bala Munipalli, Chrisandra L. Shufelt, Paldeep S. Atwal, Dacre R. T. Knight

Get full text